Quantcast
Last updated on April 23, 2014 at 1:22 EDT

Latest Diabetes management Stories

2014-02-25 08:31:50

Once-Weekly Dulaglutide Hits Primary Endpoint in Sixth Consecutive AWARD Trial INDIANAPOLIS, Feb. 25, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced positive top-line results of the sixth AWARD (Assessment of Weekly AdministRation of LY2189265 in Diabetes) trial for once-weekly dulaglutide, an investigational, long-acting glucagon-like peptide 1 (GLP-1) receptor agonist being studied as a treatment for type 2 diabetes. In the AWARD-6 study, once-weekly...

2014-02-21 08:25:23

Trial Seeks to Examine the Effects of INVOKANA® on the Progression of Diabetic Nephropathy RARITAN, N.J., Feb. 21, 2014 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) today announced the initiation of CREDENCE (Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation), a global, multicenter study of INVOKANA(®) (canagliflozin). This Phase 3 study is a randomized, double-blind, placebo-controlled, parallel group trial designed to enroll...

2014-02-20 08:29:50

Proceeds to be used to continue the launch of the DarioTM Diabetes Management Solution CAESAREA, Israel, Feb. 20, 2014 /PRNewswire/ -- LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, announced today that it has successfully closed its previously announced $4.19 million common stock and warrant private placement financing that priced on February 13, 2014. LabStyle intends to use the aggregate net proceeds of the financing,...

2014-02-18 08:32:39

To widen market potential, pharma companies must roll out long-lasting therapies that delay or prevent disease progression BUENOS AIRES, Argentina, Feb. 18, 2014 /PRNewswire/ -- The Latin American diabetes therapeutics market will experience major changes within the next three years due to the launch of innovative drugs that include three long-acting insulins and four non-insulin treatments. Nevertheless, pharmaceutical companies should continue their research to develop treatments that can...

2014-02-12 12:31:50

In an unprecedented, challenging environment for reimbursement and choice for people with diabetes, ACCU-CHEK remains highest ranked brand INDIANAPOLIS, Feb. 12, 2014 /PRNewswire/ -- J.D. Power has announced that Roche Diabetes Care's ACCU-CHEK products rank "Highest in Customer Satisfaction with Blood Glucose Meters" among adults living with diabetes in the U.S. for the second year in a row according to the 2013 Blood Glucose Meter Satisfaction Study(SM). In a study comprised of...

2014-02-12 08:28:24

Clinical program focused on reversing type 1 diabetes symptoms in patients diagnosed within six months of trial initiation EDGEWATER, N.J. and SAN DIEGO, Feb. 12, 2014 /PRNewswire/ -- DiaVacs, Inc., a clinical stage biotechnology company focused on developing cell-based therapy for treatment of type 1 diabetes, and Profil(® )Institute for Clinical Research, Inc., an early phase clinical research organization focused on diabetes and obesity, announced today a strategic collaboration...

2014-02-11 23:28:04

Achieve is conducting a placebo-controlled, multicenter study to evaluate the blood pressure reduction with ambulatory blood pressure monitoring (ABPM), safety, and tolerability of a new drug in the treatment of subjects with hypertension and type 2 diabetes mellitus. Birmingham, AL (PRWEB) February 11, 2014 Achieve is conducting a placebo-controlled, multicenter study to evaluate the blood pressure reduction with ambulatory blood pressure monitoring (ABPM), safety, and tolerability of a...

2014-02-11 08:30:24

Research advances in novel pathways produce innovative antidiabetic drugs, which will pave the way for successful market penetration LONDON, Feb. 11, 2014 /PRNewswire/ -- Type 2 diabetes is one of the most significant global health concerns of modern times. According to the International Diabetes Federation, more than 55 million people have been diagnosed with diabetes in Europe in 2012, and this number is expected to rise to 64 million by 2030. A recent research by Frost &...

2014-02-06 23:02:31

Niche Publishing Leader Now Offers Five Wellness Titles BOSTON, MA (PRWEB) February 06, 2014 Madavor Media, LLC a specialty media company and one of the publishing industry’s fastest-growing providers of niche consumer content, has acquired Diabetic CookingTM magazine, which exclusively addresses diabetes control through dietary management and simple, healthful, recipes. This acquisition adds a fifth title to Madavor Media’s rapidly expanding Wellness division, which grew...

2014-02-04 08:33:53

CAESAREA, Israel, Feb. 4, 2014 /PRNewswire/ -- LabStyle Innovations Corp. (OTCQB:DRIO), developer of the Dario((TM)) Diabetes Management Platform, announced today that the company has signed an agreement with uHealth Australia Pty Limited (uHealth), a leading distributor of digital health and surgical innovations, to exclusively distribute in Australia the Dario((TM)) blood glucose monitoring device, one of the three main components of the Dario((TM)) platform. "We are excited to...


Latest Diabetes management Reference Libraries

Diabetes Care
2012-05-12 21:41:27

Diabetes Care is a peer-reviewed medical journal established in 1978 and published monthly by the American Diabetes Association. It covers research in the following five categories: clinical care/education/nutrition/psychosocial research; epidemiology/health services research; emerging treatments and technologies; pathophysiology/complications; and cardiovascular and metabolic risk. The journal also publishes clinically relevant review articles, letters to the editor, and commentaries....

More Articles (1 articles) »